HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-Xue Wang Selected Research

Xiao-Xue Wang Research Topics

Disease

5Neoplasms (Cancer)
01/2020 - 08/2015
2Hematologic Neoplasms (Hematological Malignancy)
07/2022 - 08/2015
2Infections
10/2020 - 10/2015
2Hepatocellular Carcinoma (Hepatoma)
01/2018 - 11/2016
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
08/2022
1Residual Neoplasm
07/2022
1Ovarian Neoplasms (Ovarian Cancer)
06/2021
1Hemorrhage
06/2021
1Inflammation (Inflammations)
09/2020
1Obesity
09/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2020
1Adenocarcinoma
01/2020
1Threatened Abortion
04/2019
1Spontaneous Abortion (Miscarriage)
04/2019
1Dementia (Dementias)
01/2019
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2017
1Hematoma
01/2016
1Hemorrhoids
09/2012

Drug/Important Bio-Agent (IBA)

4MicroRNAs (MicroRNA)IBA
04/2019 - 08/2015
1ElectrolytesIBA
08/2022
1Indicators and Reagents (Reagents)IBA
07/2022
1TeicoplaninIBA
10/2020
1Nonesterified Fatty Acids (NEFA)IBA
09/2020
1BerberineIBA
09/2020
1Long Noncoding RNAIBA
09/2020
1HexokinaseIBA
01/2020
1GemcitabineFDA Link
01/2020
1ikarugamycinIBA
01/2020
1DydrogesteroneFDA Link
04/2019
1ProgesteroneFDA LinkGeneric
04/2019
1Iodine-125IBA
01/2018
1metuximabIBA
11/2016
1Interleukin-1 (Interleukin 1)IBA
01/2016
1salicylhydroxamic acid (SHAM)IBA
01/2016
1Ethanol (Ethyl Alcohol)IBA
01/2016
1Toll-Like Receptors (Toll-Like Receptor)IBA
10/2015

Therapy/Procedure

2Therapeutics
07/2022 - 12/2018
2Drug Therapy (Chemotherapy)
06/2021 - 01/2020
1Cytoreduction Surgical Procedures
06/2021
1Hyperthermic Intraperitoneal Chemotherapy
06/2021
1Intravaginal Administration
04/2019
1Proctoscopes (Proctoscope)
09/2012